154:@0.085199:0.957873:0.109688:0.957873:0.109688:0.938882:0.085199:0.938882:0.007305:0.008593:0.008591
6:@0.038824:0.497523:0.060302:0.497523:0.060302:0.450045:0.038824:0.450045:0.021478
CHAPTER 6:@0.117647:0.067219:0.190817:0.067219:0.190817:0.047140:0.117647:0.047140:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008716
junction. PCR primers are designed on both sides of the fusion. A PCR with breakpoint-spanning :@0.117647:0.118547:0.857207:0.118547:0.857207:0.100701:0.117647:0.100701:0.004594:0.009917:0.010141:0.008031:0.005790:0.005005:0.009299:0.010216:0.004258:0.004856:0.010515:0.012420:0.011598:0.004856:0.009562:0.007041:0.005005:0.015221:0.007937:0.006815:0.006854:0.004856:0.008031:0.006686:0.007937:0.004856:0.009861:0.007937:0.006854:0.005005:0.008834:0.010141:0.008029:0.009861:0.004856:0.009301:0.010216:0.004856:0.009656:0.009320:0.005808:0.009973:0.004856:0.006854:0.005005:0.009861:0.007937:0.006854:0.004856:0.009301:0.005528:0.004856:0.005808:0.009899:0.007937:0.004856:0.005640:0.009861:0.006854:0.005005:0.009301:0.010216:0.004258:0.004856:0.012905:0.004856:0.010515:0.012420:0.011598:0.004856:0.012849:0.004779:0.005808:0.009973:0.004856:0.009264:0.006686:0.008050:0.008292:0.009021:0.009955:0.009301:0.005005:0.009861:0.005696:0.006649:0.006759:0.009880:0.008031:0.010216:0.010216:0.005005:0.010067:0.008741:0.004240
primers :@0.117647:0.134716:0.180323:0.134716:0.180323:0.116870:0.117647:0.116870:0.009562:0.007041:0.005005:0.015221:0.007937:0.006815:0.006854:0.004240
will only result in a product for the rearrangement. :@0.183634:0.135245:0.637716:0.135245:0.637716:0.115416:0.183634:0.115416:0.014277:0.005665:0.005354:0.005250:0.008384:0.010334:0.011455:0.005105:0.009525:0.008384:0.007429:0.008819:0.007512:0.011121:0.005001:0.006329:0.008384:0.005561:0.011351:0.008384:0.009110:0.008384:0.010625:0.007429:0.010770:0.010708:0.011019:0.008921:0.006329:0.008384:0.005956:0.010334:0.007699:0.008384:0.006454:0.010998:0.008819:0.008384:0.007429:0.008944:0.008923:0.007823:0.007699:0.008923:0.011185:0.009546:0.008819:0.016913:0.008819:0.010957:0.006329:0.004731:0.004711
(B):@0.641429:0.134819:0.667804:0.134819:0.667804:0.115607:0.641429:0.115607:0.006931:0.012513:0.006931
 Schematic outline of :@0.667804:0.135245:0.857638:0.135245:0.857638:0.115416:0.667804:0.115416:0.008384:0.010127:0.008653:0.010998:0.008819:0.016933:0.008716:0.006433:0.005561:0.008778:0.008384:0.010355:0.010770:0.006454:0.005250:0.005561:0.011268:0.008819:0.008384:0.010332:0.006142:0.004711
KMT2A:@0.117647:0.151414:0.185567:0.151414:0.185567:0.131394:0.117647:0.131394:0.013551:0.018178:0.012513:0.009899:0.013779
 with its two breakpoint clusters (major: red; minor: green). Scissors indicate :@0.185566:0.151414:0.857620:0.151414:0.857620:0.131585:0.185566:0.131585:0.007948:0.014277:0.005312:0.006454:0.011081:0.007948:0.005310:0.006329:0.007616:0.007948:0.006389:0.014049:0.010583:0.007948:0.010293:0.007429:0.008944:0.009214:0.010023:0.011061:0.010332:0.005561:0.010957:0.006329:0.007948:0.008653:0.005001:0.010957:0.007510:0.006207:0.008819:0.007572:0.007616:0.007948:0.007180:0.016933:0.008716:0.005416:0.010334:0.008197:0.004731:0.007948:0.007429:0.008923:0.010957:0.004731:0.007948:0.016996:0.005561:0.011268:0.010334:0.008197:0.004731:0.007948:0.009816:0.007429:0.008923:0.008819:0.011351:0.007180:0.004731:0.007948:0.010127:0.008778:0.005499:0.007512:0.007782:0.010334:0.007574:0.007616:0.007948:0.005561:0.011268:0.010957:0.005561:0.008840:0.008716:0.006205:0.008819:0.004711
where the crRNAs target Cas9 to cut and arrows indicate the desired sequencing direction. :@0.117647:0.167583:0.857716:0.167583:0.857716:0.147754:0.117647:0.147754:0.014360:0.010998:0.008819:0.007429:0.008819:0.003735:0.006452:0.010998:0.008819:0.003735:0.008778:0.007699:0.012887:0.014630:0.014007:0.007616:0.003725:0.006454:0.008923:0.007533:0.009546:0.008819:0.006329:0.003735:0.013987:0.009048:0.007616:0.009961:0.003725:0.006205:0.010583:0.003735:0.008923:0.010770:0.006329:0.003735:0.008923:0.011268:0.010957:0.003735:0.008923:0.007821:0.007429:0.010253:0.014215:0.007616:0.003725:0.005561:0.011268:0.010957:0.005561:0.008840:0.008716:0.006205:0.008819:0.003725:0.006454:0.010998:0.008819:0.003735:0.010957:0.008819:0.007616:0.005561:0.007429:0.008923:0.010957:0.003725:0.007782:0.008923:0.010397:0.011019:0.008819:0.011268:0.008778:0.005561:0.011183:0.009712:0.003735:0.010957:0.005561:0.007429:0.008923:0.008923:0.006433:0.005561:0.010332:0.011351:0.004731:0.004711
(C):@0.117647:0.183326:0.144935:0.183326:0.144935:0.164114:0.117647:0.164114:0.006931:0.013426:0.006931
 Schematic outline of :@0.144935:0.183752:0.327485:0.183752:0.327485:0.163923:0.144935:0.163923:0.005956:0.010127:0.008651:0.010998:0.008819:0.016933:0.008716:0.006433:0.005561:0.008778:0.005956:0.010357:0.010770:0.006452:0.005250:0.005561:0.011268:0.008819:0.005956:0.010334:0.006142:0.004711
SIL:@0.328726:0.183752:0.356264:0.183752:0.356264:0.163732:0.328726:0.163732:0.009546:0.006952:0.011040
 and :@0.356263:0.183752:0.398078:0.183752:0.398078:0.163923:0.356263:0.163923:0.005956:0.008923:0.011268:0.010957:0.004711
TAL1:@0.399321:0.183752:0.445245:0.183752:0.445245:0.163732:0.399321:0.163732:0.011206:0.013779:0.011040:0.009899
. Common breakpoint areas are highlighted by a :@0.445244:0.183752:0.857656:0.183752:0.857656:0.163923:0.445244:0.163923:0.004731:0.005956:0.014111:0.010332:0.016996:0.016913:0.010334:0.011351:0.005956:0.010293:0.007429:0.008944:0.009214:0.010023:0.011059:0.010334:0.005561:0.010957:0.006329:0.005956:0.008923:0.007429:0.008944:0.009048:0.007616:0.005956:0.008923:0.007429:0.008819:0.005956:0.011081:0.005561:0.009855:0.011185:0.005250:0.005561:0.009857:0.010687:0.006205:0.008923:0.010957:0.005956:0.010210:0.009525:0.005956:0.009110:0.004711
blue box. Scissors indicate where the crRNAs target Cas9 to cut and arrows indicate the :@0.117647:0.199921:0.857664:0.199921:0.857664:0.180092:0.117647:0.180092:0.010397:0.005001:0.011019:0.008819:0.005748:0.010729:0.010251:0.009795:0.004731:0.005748:0.010127:0.008778:0.005499:0.007512:0.007780:0.010334:0.007574:0.007616:0.005748:0.005561:0.011268:0.010957:0.005561:0.008840:0.008714:0.006205:0.008819:0.005748:0.014360:0.010998:0.008819:0.007429:0.008819:0.005748:0.006454:0.010998:0.008819:0.005748:0.008778:0.007699:0.012887:0.014628:0.014007:0.007616:0.005748:0.006454:0.008923:0.007533:0.009546:0.008819:0.006329:0.005748:0.013987:0.009048:0.007616:0.009961:0.005748:0.006205:0.010583:0.005748:0.008923:0.010770:0.006329:0.005748:0.008923:0.011268:0.010957:0.005748:0.008923:0.007823:0.007429:0.010251:0.014215:0.007616:0.005748:0.005561:0.011266:0.010957:0.005561:0.008840:0.008716:0.006205:0.008819:0.005748:0.006456:0.010998:0.008819:0.004711
desired sequencing direction. Genomic regions are not scaled. :@0.117647:0.216090:0.635452:0.216090:0.635452:0.196261:0.117647:0.196261:0.010957:0.008819:0.007616:0.005561:0.007429:0.008923:0.010957:0.004711:0.007780:0.008923:0.010397:0.011019:0.008819:0.011268:0.008778:0.005561:0.011185:0.009712:0.004711:0.010957:0.005561:0.007427:0.008923:0.008923:0.006431:0.005561:0.010334:0.011351:0.004731:0.004711:0.015003:0.008819:0.011268:0.010334:0.016996:0.005561:0.008778:0.004711:0.007429:0.008819:0.009813:0.005561:0.010334:0.011185:0.007616:0.004711:0.008923:0.007429:0.008819:0.004711:0.011268:0.010355:0.006329:0.004711:0.007782:0.008838:0.009214:0.005250:0.008923:0.010832:0.004731:0.004711
We performed target enrichment for each sample with appropriate sets of crRNAs (:@0.117647:0.254515:0.811421:0.254515:0.811421:0.234142:0.117647:0.234142:0.018649:0.009039:0.003812:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.003812:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.003812:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.003812:0.006026:0.010843:0.007807:0.003812:0.009291:0.009291:0.008765:0.011459:0.003812:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.003812:0.014723:0.005273:0.006620:0.011459:0.003812:0.008811:0.011048:0.011071:0.007442:0.010820:0.011071:0.007807:0.005798:0.008811:0.006209:0.009039:0.003812:0.007875:0.009131:0.006437:0.007670:0.003812:0.010843:0.006209:0.003812:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.003812:0.006939
Sup-:@0.811511:0.254515:0.852941:0.254515:0.852941:0.233382:0.811511:0.233382:0.010455:0.011893:0.011869:0.007213
plementary Table 1:@0.117647:0.275093:0.289530:0.275093:0.289530:0.253960:0.117647:0.253960:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005239:0.011413:0.009679:0.011528:0.005935:0.009473:0.005236:0.010911
) and sequenced each sample on one Oxford Nanopore Technolo-:@0.289530:0.275093:0.852941:0.275093:0.852941:0.254720:0.289530:0.254720:0.006939:0.005364:0.009085:0.011596:0.011391:0.005364:0.007873:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009108:0.011391:0.005364:0.009291:0.009291:0.008765:0.011459:0.005364:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.005364:0.010843:0.011756:0.005364:0.010843:0.011598:0.009039:0.005364:0.016298:0.010089:0.006026:0.010843:0.007442:0.011391:0.005364:0.015545:0.009085:0.011596:0.010820:0.011505:0.010843:0.007442:0.009039:0.005364:0.010866:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.010980:0.007533
gies MinION flow cell (R9.4). After mapping to the reference genome (GRCh38), the ge-:@0.117647:0.295672:0.852941:0.295672:0.852941:0.275299:0.117647:0.275299:0.009861:0.005547:0.009039:0.007670:0.003721:0.019426:0.005615:0.011756:0.006825:0.016047:0.016230:0.003721:0.005638:0.005570:0.010866:0.014723:0.003721:0.008994:0.008948:0.005387:0.005250:0.003721:0.006939:0.013376:0.010432:0.004497:0.010432:0.006939:0.004497:0.003721:0.014929:0.006197:0.005969:0.009039:0.007807:0.003721:0.017577:0.008811:0.011048:0.011071:0.005615:0.011459:0.009861:0.003721:0.006209:0.011048:0.003721:0.006620:0.011299:0.009039:0.003721:0.007442:0.009039:0.006026:0.009039:0.007442:0.009039:0.011596:0.008994:0.009039:0.003721:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.003721:0.006939:0.015682:0.013308:0.014746:0.011459:0.010432:0.010432:0.006939:0.004497:0.003721:0.006620:0.011299:0.009039:0.003721:0.009656:0.008923:0.007533
nome wide coverage per sample was 0.028x (B-ALL1), 0.04x (B-ALL2), 0.10x (B-ALL3), :@0.117647:0.316251:0.857121:0.316251:0.857121:0.295878:0.117647:0.295878:0.011596:0.010843:0.017485:0.009039:0.003835:0.014723:0.005547:0.011322:0.009039:0.003835:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.003835:0.011505:0.009039:0.007807:0.003835:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.003835:0.014723:0.009291:0.007670:0.003835:0.010432:0.004497:0.010432:0.010432:0.010432:0.010089:0.003835:0.006939:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.003835:0.010432:0.004497:0.010432:0.010432:0.010089:0.003835:0.006939:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.003835:0.010432:0.004497:0.010432:0.010432:0.010089:0.003835:0.006939:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.004109
0.54x (B-ALL4), 0.67x (B-ALL5), 0.22x (T-ALL1), 0.17x (T-ALL2), 0.032x (T-ALL3), :@0.117647:0.336829:0.857121:0.336829:0.857121:0.316456:0.117647:0.316456:0.010432:0.004497:0.010432:0.010432:0.010089:0.006962:0.006939:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.006962:0.010432:0.004497:0.010432:0.010432:0.010089:0.006962:0.006939:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.006951:0.010432:0.004497:0.010432:0.010432:0.010089:0.006962:0.006823:0.011804:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.006951:0.010432:0.004497:0.010432:0.010432:0.010089:0.006962:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.006962:0.010432:0.004497:0.010432:0.010432:0.010432:0.010089:0.006962:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.004109
0.12x (T-ALL4) and 0.037x (T-ALL5) (:@0.117647:0.357408:0.453178:0.357408:0.453178:0.337035:0.117647:0.337035:0.010432:0.004497:0.010432:0.010432:0.010089:0.006186:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.006186:0.009085:0.011596:0.011391:0.006186:0.010432:0.004497:0.010432:0.010432:0.010432:0.010089:0.006186:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.006186:0.006939
Supplementary Table 1:@0.453174:0.357408:0.660761:0.357408:0.660761:0.336275:0.453174:0.336275:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.006049:0.011413:0.009679:0.011528:0.005935:0.009473:0.006049:0.010911
). However, due to the :@0.660760:0.357408:0.857048:0.357408:0.857048:0.337035:0.660760:0.337035:0.006939:0.004497:0.006186:0.016207:0.010866:0.014518:0.009336:0.009633:0.009039:0.006255:0.004497:0.006186:0.011048:0.011345:0.009039:0.006186:0.006209:0.011048:0.006186:0.006620:0.011299:0.009039:0.004109
targeted sequencing approach, on-target coverages increased to 2-352x for the KMT2A :@0.117647:0.377987:0.857141:0.377987:0.857141:0.357614:0.117647:0.357614:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.004520:0.007875:0.009108:0.010703:0.011347:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004520:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011459:0.004497:0.004520:0.010843:0.011756:0.007533:0.006549:0.009087:0.007624:0.009656:0.009131:0.006437:0.004520:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.007670:0.004520:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007873:0.009108:0.011391:0.004520:0.006209:0.011048:0.004520:0.010432:0.007533:0.010432:0.010432:0.010432:0.010089:0.004520:0.006026:0.010843:0.007807:0.004520:0.006620:0.011299:0.009039:0.004520:0.014541:0.019608:0.013354:0.010432:0.014929:0.004109
locus in the B-ALL samples and 47-290x at the :@0.117647:0.398566:0.509902:0.398566:0.509902:0.378193:0.117647:0.378193:0.005182:0.011276:0.009108:0.011413:0.007670:0.003675:0.005615:0.011756:0.003675:0.006620:0.011299:0.009039:0.003675:0.012646:0.007533:0.014929:0.011619:0.011619:0.003675:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.003675:0.009085:0.011596:0.011391:0.003675:0.010432:0.010432:0.007533:0.010432:0.010432:0.010432:0.010089:0.003675:0.008811:0.006437:0.003675:0.006620:0.011299:0.009039:0.004109
SIL:@0.509531:0.399034:0.539822:0.399034:0.539822:0.377012:0.509531:0.377012:0.010500:0.007647:0.012144
 and :@0.539822:0.398566:0.579680:0.398566:0.579680:0.378193:0.539822:0.378193:0.003675:0.009085:0.011596:0.011393:0.004109
TAL1:@0.579259:0.399034:0.629774:0.399034:0.629774:0.377012:0.579259:0.377012:0.012326:0.015157:0.012144:0.010888
 loci in the T-ALL samples. :@0.629774:0.398566:0.857012:0.398566:0.857012:0.378193:0.629774:0.378193:0.003675:0.005182:0.011276:0.008994:0.005615:0.003675:0.005615:0.011756:0.003675:0.006620:0.011299:0.009039:0.003675:0.011799:0.007533:0.014929:0.011619:0.011619:0.003675:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004497:0.004109
(:@0.117647:0.419144:0.124586:0.419144:0.124586:0.398771:0.117647:0.398771:0.006939
Figure 2A and Supplementary Table 1:@0.124586:0.419144:0.458038:0.419144:0.458038:0.398011:0.124586:0.398011:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004018:0.010911:0.015089:0.004018:0.009653:0.012167:0.011870:0.004018:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004018:0.011413:0.009679:0.011528:0.005935:0.009473:0.004018:0.010911
). :@0.458036:0.419144:0.473581:0.419144:0.473581:0.398771:0.458036:0.398771:0.006939:0.004497:0.004109
To detect :@0.117647:0.439723:0.199504:0.439723:0.199504:0.419350:0.117647:0.419350:0.010866:0.011048:0.004520:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.004109
KMT2A:@0.199910:0.440192:0.274622:0.440192:0.274622:0.418170:0.199910:0.418170:0.014906:0.019996:0.013765:0.010888:0.015157
 fusion genes we applied NanoFG, which we previously developed to :@0.274622:0.439723:0.857063:0.439723:0.857063:0.419350:0.274622:0.419350:0.004520:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004520:0.009656:0.009039:0.011596:0.009039:0.007670:0.004520:0.014520:0.009039:0.004520:0.008811:0.011048:0.011162:0.005250:0.005547:0.009106:0.011391:0.004520:0.015543:0.009087:0.011596:0.011048:0.011276:0.015682:0.004497:0.004520:0.014789:0.011459:0.005547:0.008765:0.011459:0.004520:0.014516:0.009039:0.004520:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007556:0.005182:0.009724:0.004520:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011502:0.009108:0.011391:0.004520:0.006209:0.011048:0.004109
identify fusion genes from nanopore sequencing data . NanoFG identified, as expected, :@0.117647:0.460302:0.857024:0.460302:0.857024:0.439929:0.117647:0.439929:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.006506:0.009724:0.003378:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.003378:0.009656:0.009039:0.011596:0.009039:0.007670:0.003378:0.006414:0.007442:0.010843:0.017645:0.003378:0.011687:0.009085:0.011596:0.010820:0.011505:0.010843:0.007442:0.009039:0.003378:0.007875:0.009106:0.010706:0.011347:0.009039:0.011596:0.008994:0.005615:0.011457:0.009861:0.003378:0.011573:0.008811:0.006551:0.009291:0.018284:0.004497:0.003378:0.015545:0.009085:0.011596:0.011048:0.011276:0.015682:0.003378:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.011117:0.004497:0.003378:0.009291:0.007670:0.003378:0.009108:0.010089:0.011502:0.009108:0.009108:0.006209:0.009108:0.011117:0.004497:0.004109
403:@0.560250:0.452686:0.578495:0.452686:0.578495:0.440808:0.560250:0.440808:0.006082:0.006082:0.006082
a :@0.117647:0.480880:0.131046:0.480880:0.131046:0.460507:0.117647:0.460507:0.009291:0.004109
KMT2A-MLLT1:@0.130741:0.481349:0.279709:0.481349:0.279709:0.459327:0.130741:0.459327:0.014906:0.019996:0.013765:0.010888:0.014563:0.007624:0.019996:0.012144:0.010432:0.013765:0.010888
 fusion gene with two fusion-supporting reads in the B-ALL2 sample :@0.279708:0.480880:0.857134:0.480880:0.857134:0.460507:0.279708:0.460507:0.003812:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.003812:0.009656:0.009039:0.011596:0.009039:0.003812:0.014723:0.005273:0.006620:0.011459:0.003812:0.006437:0.014518:0.011048:0.003812:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.007533:0.007510:0.011071:0.011048:0.011505:0.010843:0.007964:0.006437:0.005615:0.011459:0.009861:0.003812:0.007442:0.009291:0.009291:0.011391:0.007670:0.003812:0.005615:0.011756:0.003812:0.006620:0.011302:0.009039:0.003812:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.003812:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.004109
(:@0.117647:0.501459:0.124586:0.501459:0.124586:0.481086:0.117647:0.481086:0.006939
Supplementary Table 2:@0.124586:0.501459:0.330484:0.501459:0.330484:0.480326:0.124586:0.480326:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005205:0.011413:0.009679:0.011528:0.005935:0.009473:0.005205:0.010911
). For the blinded samples B-ALL3 and B-ALL5 we identified :@0.330472:0.501459:0.857063:0.501459:0.857063:0.481086:0.330472:0.481086:0.006939:0.004497:0.005319:0.010685:0.010840:0.007807:0.005319:0.006620:0.011299:0.009039:0.005319:0.010911:0.005250:0.005615:0.011596:0.011322:0.009108:0.011391:0.005319:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.005319:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.005319:0.009085:0.011596:0.011391:0.005319:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.005319:0.014518:0.009039:0.005319:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.011391:0.004109
a :@0.117647:0.522038:0.131046:0.522038:0.131046:0.501665:0.117647:0.501665:0.009291:0.004109
KMT2A-MLLT2 :@0.131124:0.522507:0.285319:0.522507:0.285319:0.500484:0.131124:0.500484:0.014906:0.019996:0.013765:0.010888:0.014563:0.007624:0.019996:0.012144:0.010432:0.013765:0.010888:0.005227
fusion with four and 31 fusion-supporting reads respectively, which :@0.285418:0.522038:0.856975:0.522038:0.856975:0.501665:0.285418:0.501665:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004177:0.014723:0.005273:0.006620:0.011459:0.004177:0.006026:0.010820:0.011413:0.007807:0.004177:0.009085:0.011596:0.011391:0.004177:0.010432:0.010432:0.004177:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.007533:0.007510:0.011071:0.011048:0.011505:0.010843:0.007964:0.006437:0.005615:0.011459:0.009861:0.004177:0.007444:0.009288:0.009291:0.011391:0.007670:0.004177:0.007442:0.009039:0.007512:0.011502:0.009108:0.009108:0.006437:0.005547:0.009633:0.008948:0.005182:0.007989:0.004497:0.004177:0.014792:0.011459:0.005547:0.008765:0.011459:0.004109
was later confirmed by comparison with outsourced results obtained from a laboratory :@0.117647:0.542616:0.857000:0.542616:0.857000:0.522244:0.117647:0.522244:0.014723:0.009291:0.007670:0.004748:0.005433:0.008811:0.006209:0.009039:0.007807:0.004748:0.008994:0.010843:0.011756:0.005684:0.005684:0.007807:0.017485:0.009106:0.011391:0.004748:0.010843:0.009724:0.004748:0.008994:0.010843:0.017280:0.011368:0.009085:0.007807:0.005615:0.007875:0.010843:0.011756:0.004748:0.014723:0.005273:0.006617:0.011459:0.004748:0.010820:0.011071:0.006437:0.007875:0.010820:0.011413:0.007442:0.008994:0.009108:0.011391:0.004748:0.007442:0.009039:0.007510:0.011550:0.004908:0.006437:0.007670:0.004748:0.010957:0.010797:0.006551:0.009085:0.005615:0.011596:0.009108:0.011391:0.004748:0.006412:0.007442:0.010843:0.017645:0.004748:0.009291:0.004748:0.005433:0.009108:0.011254:0.010843:0.007898:0.008811:0.006209:0.010843:0.008400:0.009724:0.004109
specializing in KMT2A partner detection. In addition to this fusion result, a reciprocal :@0.117647:0.563195:0.856977:0.563195:0.856977:0.542822:0.117647:0.542822:0.007510:0.011505:0.009108:0.008994:0.005798:0.009405:0.005250:0.005615:0.008834:0.005615:0.011457:0.009861:0.005090:0.005615:0.011756:0.005090:0.014541:0.019608:0.013354:0.010432:0.014929:0.005090:0.011365:0.009087:0.007964:0.006437:0.011598:0.009039:0.007807:0.005090:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.004497:0.005090:0.006894:0.011756:0.005090:0.009291:0.011322:0.011391:0.005273:0.006437:0.005547:0.010843:0.011756:0.005090:0.006209:0.011048:0.005090:0.006620:0.011459:0.005615:0.007670:0.005090:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.005090:0.007442:0.009039:0.007510:0.011550:0.004908:0.006437:0.004497:0.005090:0.009291:0.005090:0.007442:0.009106:0.008994:0.005271:0.011071:0.007442:0.011276:0.009108:0.009405:0.005250:0.004109
MLLT2-KMT2A:@0.117647:0.584243:0.267208:0.584243:0.267208:0.562221:0.117647:0.562221:0.019996:0.012144:0.010432:0.013765:0.010888:0.007624:0.014906:0.019996:0.013765:0.010888:0.015157
 fusion was detected in the B-ALL5 sample with 28 fusion-supporting :@0.267207:0.583774:0.857126:0.583774:0.857126:0.563401:0.267207:0.563401:0.004291:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004291:0.014723:0.009291:0.007670:0.004291:0.011322:0.009131:0.006211:0.009106:0.009108:0.006209:0.009108:0.011391:0.004291:0.005615:0.011756:0.004291:0.006617:0.011302:0.009039:0.004291:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004280:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.004291:0.014723:0.005271:0.006620:0.011459:0.004291:0.010432:0.010432:0.004291:0.006366:0.011413:0.007601:0.005547:0.010843:0.011756:0.007533:0.007510:0.011071:0.011048:0.011505:0.010843:0.007967:0.006437:0.005615:0.011459:0.009861:0.004109
reads that was not previously detected (:@0.117647:0.604353:0.443796:0.604353:0.443796:0.583980:0.117647:0.583980:0.007442:0.009291:0.009291:0.011391:0.007670:0.003470:0.006620:0.011391:0.008811:0.006437:0.003470:0.014723:0.009291:0.007670:0.003470:0.011596:0.010822:0.006437:0.003470:0.011071:0.007442:0.009336:0.009838:0.005547:0.010820:0.011413:0.007556:0.005182:0.009724:0.003470:0.011322:0.009128:0.006211:0.009106:0.009108:0.006209:0.009108:0.011391:0.003470:0.006939
Supplementary Figure 2, Supplementary Table :@0.443747:0.604353:0.856930:0.604353:0.856930:0.583220:0.443747:0.583220:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.003378:0.011596:0.006209:0.010749:0.011893:0.008263:0.009473:0.003378:0.010911:0.005433:0.003378:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.003378:0.011413:0.009676:0.011528:0.005935:0.009473:0.004018
2:@0.117647:0.624931:0.128558:0.624931:0.128558:0.603798:0.117647:0.603798:0.010911
). For B-ALL4, the diagnostic laboratory identified a :@0.128558:0.624931:0.572674:0.624931:0.572674:0.604558:0.128558:0.604558:0.006939:0.004497:0.004679:0.010683:0.010843:0.007807:0.004679:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.004679:0.006620:0.011299:0.009039:0.004679:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.004679:0.005433:0.009108:0.011254:0.010843:0.007898:0.008811:0.006209:0.010843:0.008400:0.009724:0.004679:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009106:0.011391:0.004679:0.009291:0.004109
KMT2A-MLLT2:@0.573209:0.625400:0.722176:0.625400:0.722176:0.603378:0.573209:0.603378:0.014906:0.019996:0.013765:0.010888:0.014563:0.007624:0.019996:0.012144:0.010432:0.013765:0.010888
 fusion, howev-:@0.722175:0.624931:0.852941:0.624931:0.852941:0.604558:0.722175:0.604558:0.004679:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004497:0.004679:0.011299:0.010866:0.014518:0.009336:0.009829:0.007533
er, neither manual investigation in IGV genome browser  nor NanoFG could confirm :@0.117647:0.645510:0.857027:0.645510:0.857027:0.625137:0.117647:0.625137:0.009039:0.006255:0.004497:0.004702:0.011596:0.009039:0.005273:0.006620:0.011299:0.009039:0.007807:0.004702:0.017577:0.009085:0.011391:0.011596:0.009405:0.005250:0.004702:0.005615:0.011368:0.009633:0.009039:0.007510:0.006437:0.005615:0.009861:0.008811:0.006437:0.005547:0.010843:0.011756:0.004702:0.005615:0.011756:0.004702:0.006825:0.015682:0.015089:0.004702:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.004702:0.010820:0.007442:0.010866:0.014723:0.007875:0.009039:0.007807:0.018282:0.004702:0.011596:0.010843:0.007807:0.004702:0.015545:0.009085:0.011596:0.011048:0.011276:0.015682:0.004702:0.008994:0.010818:0.011550:0.005184:0.011391:0.004702:0.008994:0.010843:0.011756:0.005684:0.005684:0.007807:0.017645:0.004109
405:@0.595038:0.637894:0.613284:0.637894:0.613284:0.626016:0.595038:0.626016:0.006082:0.006082:0.006082
this fusion within our targeted sequencing data. In accordance with diagnostic efforts, :@0.117647:0.666089:0.857048:0.666089:0.857048:0.645716:0.117647:0.645716:0.006620:0.011459:0.005615:0.007670:0.005615:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.005615:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.005615:0.010820:0.011413:0.007807:0.005615:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.005615:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005615:0.011573:0.008811:0.006549:0.009291:0.004497:0.005615:0.006894:0.011756:0.005615:0.009291:0.008994:0.008994:0.010843:0.007442:0.011573:0.009085:0.011596:0.008994:0.009039:0.005615:0.014723:0.005273:0.006620:0.011459:0.005615:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.005615:0.009039:0.005969:0.005787:0.010843:0.007964:0.006437:0.007670:0.004497:0.004109
NanoFG did not identify genomic evidence of the :@0.117647:0.686667:0.540032:0.686667:0.540032:0.666294:0.117647:0.666294:0.015545:0.009085:0.011596:0.011048:0.011276:0.015682:0.004177:0.011391:0.005547:0.011391:0.004177:0.011596:0.010820:0.006437:0.004177:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.006503:0.009724:0.004177:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004177:0.009336:0.009838:0.005547:0.011322:0.009039:0.011596:0.008994:0.009039:0.004177:0.010843:0.006209:0.004177:0.006620:0.011299:0.009039:0.004109
KMT2A :@0.540077:0.687136:0.620017:0.687136:0.620017:0.665114:0.540077:0.665114:0.014906:0.019996:0.013765:0.010888:0.015157:0.005227
fusion for the B-ALL1 sam-:@0.620099:0.686667:0.852941:0.686667:0.852941:0.666294:0.620099:0.666294:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004177:0.006026:0.010843:0.007807:0.004177:0.006620:0.011299:0.009039:0.004177:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004177:0.007944:0.009085:0.017631:0.007533
ple. We manually confirmed the lack of fusion-spanning reads within the :@0.117647:0.707246:0.739583:0.707246:0.739583:0.686873:0.117647:0.686873:0.011162:0.005182:0.008743:0.004497:0.004748:0.018649:0.009039:0.004748:0.017577:0.009085:0.011391:0.011596:0.009405:0.005387:0.005182:0.009724:0.004748:0.008994:0.010843:0.011756:0.005684:0.005684:0.007807:0.017485:0.009108:0.011391:0.004748:0.006620:0.011299:0.009039:0.004748:0.005433:0.009291:0.008765:0.010523:0.004748:0.010843:0.006209:0.004748:0.006366:0.011413:0.007601:0.005547:0.010843:0.011756:0.007533:0.007510:0.011368:0.009085:0.011756:0.011756:0.005615:0.011459:0.009861:0.004748:0.007442:0.009291:0.009291:0.011391:0.007670:0.004748:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.004748:0.006620:0.011299:0.009039:0.004109
KMT2A :@0.740128:0.707715:0.820067:0.707715:0.820067:0.685693:0.740128:0.685693:0.014906:0.019996:0.013765:0.010888:0.015157:0.005227
and :@0.820869:0.707246:0.857049:0.707246:0.857049:0.686873:0.820869:0.686873:0.009085:0.011596:0.011391:0.004109
MLLT1 :@0.117647:0.728294:0.190099:0.728294:0.190099:0.706272:0.117647:0.706272:0.019996:0.012144:0.010432:0.013765:0.010888:0.005227
genes with IGV. NanoFG is specifically designed to detect fusion genes with :@0.193315:0.727825:0.857118:0.727825:0.857118:0.707452:0.193315:0.707452:0.009656:0.009039:0.011596:0.009039:0.007670:0.006643:0.014723:0.005271:0.006620:0.011459:0.006643:0.006825:0.015682:0.011482:0.004497:0.006643:0.015545:0.009085:0.011598:0.011048:0.011276:0.015682:0.006643:0.005615:0.007670:0.006643:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.009108:0.009405:0.005387:0.005182:0.009724:0.006643:0.011322:0.009039:0.007601:0.005615:0.009861:0.011596:0.009108:0.011391:0.006643:0.006209:0.011048:0.006643:0.011322:0.009131:0.006209:0.009108:0.009108:0.006437:0.006643:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.006643:0.009656:0.009039:0.011596:0.009039:0.007670:0.006643:0.014723:0.005273:0.006620:0.011459:0.004109
breakpoints within both of the involved fusion partners. :@0.117647:0.748403:0.592485:0.748403:0.592485:0.728031:0.117647:0.728031:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.004109:0.014723:0.005271:0.006620:0.011459:0.005615:0.011756:0.004109:0.011254:0.010820:0.006620:0.011459:0.004109:0.010843:0.006209:0.004109:0.006620:0.011299:0.009039:0.004109:0.005615:0.011365:0.009633:0.010934:0.005184:0.009633:0.009108:0.011391:0.004109:0.006366:0.011413:0.007601:0.005547:0.010843:0.011756:0.004109:0.011368:0.009085:0.007967:0.006437:0.011596:0.009039:0.007624:0.007670:0.004497:0.004109
Therefore, NanoFG did not call any of the :@0.117647:0.768982:0.473676:0.768982:0.473676:0.748609:0.117647:0.748609:0.011470:0.011311:0.009039:0.007442:0.009039:0.006026:0.010843:0.007442:0.008743:0.004497:0.004474:0.015545:0.009085:0.011596:0.011048:0.011276:0.015682:0.004474:0.011391:0.005547:0.011391:0.004474:0.011596:0.010820:0.006437:0.004474:0.009108:0.009405:0.005385:0.005250:0.004474:0.009087:0.011368:0.009724:0.004474:0.010843:0.006209:0.004474:0.006620:0.011299:0.009039:0.004109
SIL-TAL1:@0.474041:0.769451:0.562358:0.769451:0.562358:0.747429:0.474041:0.747429:0.010500:0.007647:0.012030:0.007624:0.012326:0.015157:0.012144:0.010888
 rearrangements within the T-ALL :@0.562357:0.768982:0.857051:0.768982:0.857051:0.748609:0.562357:0.748609:0.004474:0.007442:0.009291:0.009085:0.007807:0.007898:0.009085:0.011459:0.009656:0.009039:0.017485:0.009039:0.011391:0.006437:0.007670:0.004474:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.004474:0.006617:0.011302:0.009039:0.004474:0.011801:0.007533:0.014929:0.011619:0.011619:0.004109
samples as the :@0.117647:0.789561:0.248467:0.789561:0.248467:0.769188:0.117647:0.769188:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.007715:0.009291:0.007670:0.007715:0.006620:0.011299:0.009039:0.004109
SIL-TAL1 :@0.252081:0.790030:0.345625:0.790030:0.345625:0.768008:0.252081:0.768008:0.010500:0.007647:0.012030:0.007624:0.012326:0.015157:0.012144:0.010888:0.005227
rearrangement may be induced through breakpoints out-:@0.350215:0.789561:0.852941:0.789561:0.852941:0.769188:0.350215:0.769188:0.007442:0.009291:0.009085:0.007807:0.007898:0.009085:0.011459:0.009656:0.009039:0.017485:0.009039:0.011391:0.006437:0.007715:0.017577:0.008925:0.009724:0.007715:0.011254:0.009039:0.007715:0.005615:0.011596:0.011048:0.011345:0.008994:0.009108:0.011391:0.007715:0.006620:0.011459:0.007444:0.010818:0.011413:0.009930:0.011459:0.007715:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.007715:0.010820:0.011071:0.006449:0.007533
side of annotated genes (including promoter, both UTRs, and exonic/intronic regions). :@0.117647:0.810140:0.856965:0.810140:0.856965:0.789767:0.117647:0.789767:0.007601:0.005547:0.011322:0.009039:0.004931:0.010843:0.006209:0.004931:0.009085:0.011756:0.011596:0.010820:0.006551:0.008811:0.006209:0.009108:0.011391:0.004931:0.009656:0.009039:0.011596:0.009039:0.007670:0.004931:0.006939:0.005615:0.011596:0.008765:0.004908:0.011345:0.011391:0.005615:0.011459:0.009861:0.004931:0.011071:0.007442:0.010843:0.017485:0.010820:0.006209:0.009039:0.006255:0.004497:0.004931:0.011254:0.010820:0.006620:0.011459:0.004931:0.016024:0.013354:0.013376:0.007670:0.004497:0.004931:0.009085:0.011596:0.011391:0.004931:0.009108:0.009884:0.010843:0.011756:0.005547:0.008994:0.007099:0.005615:0.011391:0.006437:0.007442:0.010843:0.011756:0.005549:0.008994:0.004931:0.007442:0.009039:0.009861:0.005547:0.010845:0.011619:0.007670:0.006939:0.004497:0.004109
Therefore, we performed SV calling with Sniffles  within the :@0.117647:0.830718:0.650293:0.830718:0.650293:0.810345:0.117647:0.810345:0.011470:0.011311:0.009039:0.007442:0.009039:0.006026:0.010843:0.007442:0.008743:0.004497:0.005866:0.014518:0.009039:0.005866:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.005866:0.010112:0.015089:0.005866:0.009108:0.009405:0.005387:0.005250:0.005615:0.011459:0.009861:0.005866:0.014723:0.005273:0.006620:0.011459:0.005866:0.010112:0.011756:0.005615:0.005692:0.005692:0.005621:0.009039:0.007670:0.018222:0.005866:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.005866:0.006620:0.011302:0.009039:0.004109
342:@0.533800:0.823102:0.552045:0.823102:0.552045:0.811225:0.533800:0.811225:0.006082:0.006082:0.006082
SIL:@0.652037:0.831187:0.682328:0.831187:0.682328:0.809165:0.652037:0.809165:0.010500:0.007647:0.012144
 and :@0.682328:0.830718:0.724374:0.830718:0.724374:0.810345:0.682328:0.810345:0.005866:0.009085:0.011596:0.011391:0.004109
TAL1 :@0.726125:0.831187:0.781868:0.831187:0.781868:0.809165:0.726125:0.809165:0.012326:0.015157:0.012144:0.010888:0.005227
loci. We :@0.784099:0.830718:0.857054:0.830718:0.857054:0.810345:0.784099:0.810345:0.005182:0.011276:0.008994:0.005341:0.004497:0.005866:0.018649:0.009039:0.004109
then identified all five :@0.117647:0.851297:0.306972:0.851297:0.306972:0.830924:0.117647:0.830924:0.006620:0.011299:0.009039:0.011756:0.005113:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.011391:0.005113:0.009405:0.005387:0.005250:0.005113:0.005684:0.005615:0.009633:0.009039:0.004109
SIL-TAL1:@0.307960:0.851766:0.396277:0.851766:0.396277:0.829744:0.307960:0.829744:0.010500:0.007647:0.012030:0.007624:0.012326:0.015157:0.012144:0.010888
 rearrangements with 238x (T-ALL1), 145x (T-ALL2), :@0.396276:0.851297:0.857078:0.851297:0.857078:0.830924:0.396276:0.830924:0.005113:0.007442:0.009291:0.009085:0.007807:0.007898:0.009085:0.011459:0.009656:0.009039:0.017485:0.009039:0.011391:0.006437:0.007670:0.005113:0.014723:0.005271:0.006620:0.011459:0.005113:0.010432:0.010432:0.010432:0.010089:0.005113:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.005113:0.010432:0.010432:0.010432:0.010089:0.005113:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.004109
50x (T-ALL3), 177x (T-ALL4) and 49x (T-ALL5) breakpoint-spanning reads (:@0.117647:0.871876:0.794804:0.871876:0.794804:0.851503:0.117647:0.851503:0.010432:0.010432:0.010089:0.006802:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.004497:0.006802:0.010432:0.010432:0.010432:0.010089:0.006802:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.006802:0.009085:0.011596:0.011391:0.006802:0.010432:0.010432:0.010089:0.006802:0.006825:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.006939:0.006802:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007533:0.007510:0.011365:0.009087:0.011756:0.011756:0.005615:0.011459:0.009861:0.006802:0.007442:0.009291:0.009291:0.011391:0.007670:0.006802:0.006939
Figure :@0.794756:0.871876:0.856959:0.871876:0.856959:0.850743:0.794756:0.850743:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004018
2B, Supplementary Table 2:@0.117647:0.892454:0.354931:0.892454:0.354931:0.871321:0.117647:0.871321:0.010911:0.013194:0.005433:0.004086:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004086:0.011413:0.009679:0.011528:0.005935:0.009473:0.004086:0.010911
). While the breakpoints within :@0.354910:0.892454:0.622392:0.892454:0.622392:0.872081:0.354910:0.872081:0.006939:0.004497:0.004177:0.020704:0.011459:0.005750:0.005182:0.009039:0.004177:0.006620:0.011299:0.009039:0.004177:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.004177:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.004109
SIL:@0.622436:0.892923:0.652727:0.892923:0.652727:0.870901:0.622436:0.870901:0.010500:0.007647:0.012144
 were located within the :@0.652726:0.892454:0.857069:0.892454:0.857069:0.872081:0.652726:0.872081:0.004177:0.014518:0.009039:0.007442:0.009039:0.004177:0.005184:0.011274:0.009108:0.008811:0.006209:0.009108:0.011391:0.004177:0.014723:0.005273:0.006617:0.011459:0.005615:0.011756:0.004177:0.006620:0.011299:0.009039:0.004109
5’UTR of the gene, all breakpoints within :@0.117647:0.913033:0.476025:0.913033:0.476025:0.892660:0.117647:0.892660:0.010432:0.004291:0.016024:0.013354:0.013376:0.005513:0.010843:0.006209:0.005510:0.006620:0.011302:0.009039:0.005513:0.009653:0.009039:0.011598:0.008743:0.004497:0.005510:0.009405:0.005387:0.005250:0.005513:0.010820:0.007442:0.009291:0.009405:0.010272:0.011505:0.010843:0.005615:0.011391:0.006437:0.007670:0.005513:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.004109
TAL1 :@0.477427:0.913502:0.533170:0.913502:0.533170:0.891480:0.477427:0.891480:0.012326:0.015157:0.012144:0.010888:0.005227
were located about 185 bps upstream :@0.534956:0.913033:0.857053:0.913033:0.857053:0.892660:0.534956:0.892660:0.014518:0.009039:0.007442:0.009039:0.005513:0.005182:0.011276:0.009108:0.008811:0.006209:0.009108:0.011391:0.005513:0.009108:0.011251:0.010820:0.011073:0.006437:0.005513:0.010432:0.010432:0.010432:0.005513:0.010797:0.011185:0.007670:0.005513:0.011071:0.011185:0.007510:0.006437:0.007442:0.009291:0.009085:0.017645:0.004109